ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,880,942 | +18.8% | 170,185 | +10.1% | 0.00% | 0.0% |
| Q2 2023 | $8,319,534 | +49.8% | 154,552 | +10.5% | 0.00% | +100.0% |
| Q1 2023 | $5,554,523 | -2.4% | 139,842 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $5,693,108 | +29.5% | 141,514 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $4,396,000 | +9.0% | 136,779 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $4,032,000 | +15.1% | 135,934 | +9.1% | 0.00% | 0.0% |
| Q1 2022 | $3,503,000 | -39.6% | 124,601 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $5,795,000 | +49.2% | 125,759 | +6.2% | 0.00% | 0.0% |
| Q3 2021 | $3,885,000 | -6.5% | 118,385 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $4,156,000 | -1.7% | 118,581 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $4,230,000 | +16.8% | 117,053 | -6.1% | 0.00% | 0.0% |
| Q4 2020 | $3,621,000 | +3.8% | 124,692 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $3,490,000 | -15.8% | 123,732 | -3.4% | 0.00% | 0.0% |
| Q2 2020 | $4,144,000 | -22.6% | 128,103 | -2.5% | 0.00% | -50.0% |
| Q1 2020 | $5,353,000 | -32.5% | 131,397 | +2.2% | 0.00% | 0.0% |
| Q4 2019 | $7,931,000 | -18.2% | 128,607 | -3.4% | 0.00% | 0.0% |
| Q3 2019 | $9,701,000 | -0.9% | 133,117 | +11.8% | 0.00% | 0.0% |
| Q2 2019 | $9,785,000 | +18.9% | 119,041 | +2.1% | 0.00% | 0.0% |
| Q1 2019 | $8,227,000 | +56.0% | 116,637 | -0.4% | 0.00% | +100.0% |
| Q4 2018 | $5,274,000 | -21.0% | 117,163 | -0.8% | 0.00% | -50.0% |
| Q3 2018 | $6,676,000 | -14.4% | 118,091 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $7,803,000 | +19.6% | 116,806 | +4.2% | 0.00% | 0.0% |
| Q1 2018 | $6,526,000 | -10.9% | 112,096 | -1.3% | 0.00% | 0.0% |
| Q4 2017 | $7,321,000 | +22.7% | 113,601 | -0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,965,000 | +12.9% | 113,644 | +0.7% | 0.00% | +100.0% |
| Q2 2017 | $5,285,000 | -0.5% | 112,905 | +5.2% | 0.00% | -50.0% |
| Q1 2017 | $5,312,000 | -15.1% | 107,306 | +4.0% | 0.00% | 0.0% |
| Q4 2016 | $6,254,000 | -6.9% | 103,165 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $6,721,000 | +20.9% | 101,281 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $5,560,000 | +66.6% | 99,600 | +0.5% | 0.00% | +100.0% |
| Q1 2016 | $3,338,000 | -24.7% | 99,149 | +0.9% | 0.00% | 0.0% |
| Q4 2015 | $4,432,000 | +23.2% | 98,225 | +7.9% | 0.00% | 0.0% |
| Q3 2015 | $3,596,000 | -27.9% | 91,019 | +13.2% | 0.00% | -50.0% |
| Q2 2015 | $4,987,000 | +6.0% | 80,375 | +6.8% | 0.00% | +100.0% |
| Q1 2015 | $4,706,000 | +13.8% | 75,235 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $4,135,000 | +95.2% | 73,324 | -2.1% | 0.00% | 0.0% |
| Q3 2014 | $2,118,000 | +238.9% | 74,888 | +312.6% | 0.00% | – |
| Q2 2014 | $625,000 | +84.4% | 18,150 | +67.8% | 0.00% | – |
| Q1 2014 | $339,000 | +67.8% | 10,816 | +7.4% | 0.00% | – |
| Q4 2013 | $202,000 | – | 10,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |